Drug Type Small molecule drug |
Synonyms ADU S100, ADU-S100, MIW 815 + [2] |
Target |
Action agonists |
Mechanism STING agonists(Stimulator of interferon genes agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H24N10Na2O10P2S2 |
InChIKeyPXXGADGMBQUCOM-WUQMEGSCSA-N |
CAS Registry1638750-95-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and neck cancer metastatic | Phase 2 | United States | 26 Aug 2019 | |
Recurrent Head and Neck Carcinoma | Phase 2 | United States | 26 Aug 2019 | |
Solid tumor | Phase 1 | United States | 08 Sep 2017 | |
Solid tumor | Phase 1 | Japan | 08 Sep 2017 | |
Solid tumor | Phase 1 | Australia | 08 Sep 2017 | |
Solid tumor | Phase 1 | Canada | 08 Sep 2017 | |
Solid tumor | Phase 1 | Germany | 08 Sep 2017 | |
Solid tumor | Phase 1 | Netherlands | 08 Sep 2017 | |
Solid tumor | Phase 1 | Spain | 08 Sep 2017 | |
Solid tumor | Phase 1 | Switzerland | 08 Sep 2017 |
Phase 1 | 47 | qpqmzhvmcv(lglxcuoaps) = pyrexia 17%, chills 15%, injection-site pain 15% ivjqiapjpq (ndfuykmkjw ) | Positive | 15 Feb 2022 | |||
Phase 2 | 16 | kdogdaekmy = btnzuobvuc dzwpggibge (mgmydjmrwl, ebtsnrvwde - iknslndzvi) View more | - | 03 Jan 2022 | |||
Phase 2 | - | ADU-S100+Pembrolizumab | xtyfmnikqh(neoucsrbgf) = 4 PR ( 3 confirmed), 1 SD and 3 PD kfcsdqvylo (ousmsidnzq ) View more | Positive | 09 Dec 2020 |